Comerica (NYSE:CMA) Bolsa

Comerica

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Netflix

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

NFLX

ZION

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: CMA, NFLX, AZZ, MTX y ZION.

5 acciones en el foco este lunes: CMA, NFLX, AZZ, MTX y ZION

Comerica Inc

CHINA MINSHNG BK UNSP/ADR by China Minsheng Banking Corp., Ltd.

China Minsheng Banking Corp Ltd

CHIBOUGAMAU IND ORD by Chibougamau Independant Mines Inc

Chibougamau Independent Mines Inc

CareMax Inc

CareMax Inc WT EXP

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 1,000 points on Monday.
The Dow traded down 2.73% to 38,072.59 while the NASDAQ fell 3.19% to 15,767.59. The S&amp;P 500 also fell, dropping, 2.86% to 5,131.53.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44895495/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-delivering-high-dividend-yields-5">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer staples shares fell by just 0.7% on Monday.
In trading on Monday, consumer discretionary shares tumbled by 3.1%.
Top Headline
Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) reported better-than-expected earnings for its first quarter on Monday.
The company posted quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.15 per share. The company reported quarterly sales of $829.00 million which missed the analyst consensus estimate of $831.34 million.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) shares shot up 619% to $16.31 after the company announced a private placement with approximately $100 million in gross proceeds.</li>
<li>Shares of SHF Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>)got a boost, surging 93% to $4.12 after gaining 18% on Thursday. SHF Holdings announced a strategic partnership with FundCanna to expand access to capital for cannabis operators.</li>
<li>Wolverine World Wide, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) shares were also up, gaining 8% to $11.62. Baird analyst Jonathan Komp upgraded the rating for Wolverine World Wide from Neutral to Outperform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Thunder Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares dropped 63% to $0.0506 after the company received delisting notice from the Nasdaq.</li>
<li>Shares of New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) were down 12% to $5.03 after the company announced a $700 million proposed offering of senior notes.</li>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) was down, falling 11% to $7.26. Informa TechTarget announced the receipt of Nasdaq notification of non-compliance regarding delayed 2024 Form 10-K filing.</li>
</ul>
Commodities In commodity news, oil traded down 2.6% to $62.97 while gold traded up 3.3% at $3,439.00.
Silver traded up 1.2% to $32.850 on Monday, while copper rose 1% to $4.7835.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.29%, Germany's DAX 40 declined 0.64% and France's CAC 40 dipped 0.76%. Spain's IBEX 35 Index slipped 0.2%, while London's FTSE 100 fell 0.18%.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 falling 1.30%, China's Shanghai Composite gaining 0.45% and India's BSE Sensex gaining 1.09%.
Economics
No major economic data is scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44896269/how-to-earn-500-a-month-from-3m-stock-ahead-of-q1-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q1 Earnings</a> </li>
</ul>
Photo via Shutterstock

Equities

Eurozone

Commodities

Intraday Update

AIEV

SHF Holdings, Inc. - Class A Common Stock

SHFS

TTGT

UPXI

Dow Dips Over 1,000 Points; Comerica Earnings Top Views

Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.15 by 8.7 percent. This is a 27.55 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $829.00 million which missed the analyst consensus estimate of $831.34 million by 0.28 percent. This is a 5.74 percent increase over sales of $784.00 million the same period last year.

Comerica Q1 2025 GAAP EPS $1.25 Beats $1.15 Estimate, Sales $829.00M Miss $831.34M Estimate

U.S. stock futures fell on Monday, following a holiday-shortened week that ended with a mixed performance on Thursday. Major benchmark indices were trading lower in the premarket session.
Chinese Ministry of Commerce <a href="https://www.benzinga.com/25/04/44891949/chinese-commerce-ministry-pledges-retaliation-against-countries-isolating-beijing-with-us-at-the-expense-of-china">warned its trading partners</a> of retaliation in case of Beijing&#8217;s isolation by the U.S. "It should be pointed out in particular that China firmly opposes any party reaching a deal at the expense of China's interests," said the Ministry spokesperson, according to a translated version of the statement.
If the trading partners try to isolate Beijing, "China will never accept it and will resolutely take countermeasures in a reciprocal manner."
Meanwhile, the 10-year Treasury bond yielded 4.36% while the two-year bond was at 3.75%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing an 89% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.91%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.06%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-1.18%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.86%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Monday. The SPY was down 1.07% to $520.79, while the QQQ declined 1.17% to $438.87, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
While several S&amp;P 500 sectors posted gains on Thursday, led by energy, consumer staples, and real estate, the broader U.S. market mostly closed lower.
The Dow Jones marked its third consecutive day of losses. All major indices finished the shortened week in the red, pressured by steep declines in technology and health care.
The downturn was largely influenced by declines in information technology stocks like Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), down around 3%, and health care stocks like UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), which plummeted over 22% after <a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable">disappointing earnings</a> and guidance.
Meanwhile, Eli Lilly And Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) soared over 14% on positive weight-loss drug trial data.
Economic data from Thursday showed a decline in housing starts, a drop in jobless claims, and a sharp contraction in the Philadelphia Fed Manufacturing Index.
By Thursday&#8217;s market close, the S&amp;P 500 had fallen 14.1% from its record high of 6,147.43. The Dow Jones was down 13.15% from its 52-week peak, and the Nasdaq 100 had dropped 17.84% from its high.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.13%</td>
<td>16,286.45</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.13%</td>
<td>5,282.70</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.33%</td>
<td>39,142.23</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.92%</td>
<td>1,880.62</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to the data shared by Ryan Detrick from Carson Research, &#8220;the best and worst days tend to occur near the same time.&#8221;
He cautioned the investors with a graph of best and worst days and said, &#8220;So once again, if you sell after the worst days, odds are the best days are right around the corner.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Here&#39;s another way to show that the best and worst days tend to occur near the same time. So once again, if you sell after the worst days, odds are the best days are right around the corner. <a href="https://t.co/Kv1NLDbEUe">pic.twitter.com/Kv1NLDbEUe</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1914151166998462480?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Detrick also highlighted that after recent corrections, the S&amp;P 500&#8217;s advance/decline line has held in surprisingly well. He highlighted that the ratio was well above its January lows.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">One potential positive is the S&amp;P 500&#39;s advance/decline line has held in surprisingly well. Yes, price made new lows, but the A/D line is still well above the January lows. &#x1f914; <a href="https://t.co/pBOGHx18Yg">pic.twitter.com/pBOGHx18Yg</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1914147677635326079?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Katusa Research underscored in an X post that the market is &#8220;approaching bubble territory,&#8221; as the S&amp;P 500 Shiller CAPE ratio, or the cyclically adjusted price-to-earnings ratio, was nearly twice its historical average of 17.58.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Shiller CAPE: Approaching Bubble Territory The Cyclically Adjusted Price-to-Earnings ratio (made by Robert Shiller) smooths out short-term earnings fluctuations By using 10 years of inflation-adjusted earnings. The current CAPE ratio stands at 34.97, more than double its… <a href="https://t.co/qgmkFxkP09">pic.twitter.com/qgmkFxkP09</a>
&mdash; Katusa Research (@KatusaResearch) <a href="https://twitter.com/KatusaResearch/status/1912948966070894869?ref_src=twsrc%5Etfw">April 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44892375/dean-of-valuation-aswath-damodaran-warns-buying-the-dip-akin-to-catching-a-falling-">&#8216;Dean Of Valuation,&#8217; Aswath Damodaran</a>, also cautioned investors against the simplistic interpretation of "buying the dip" in his latest blog post.
Damodaran warned that &#8220;buying the dip&#8221; can be like &#8220;catching a falling knife,&#8221; as an initial decline might precede a much steeper and prolonged sell-off. Instead of a one-size-fits-all approach, Damodaran outlines several distinct paths for contrarian investors:
<ul>
<li>The Value Contrarian: This investor seeks out fundamentally undervalued companies that have been unfairly punished by the market. Their focus is on intrinsic value, patiently waiting for the market to recognize the discrepancy between price and worth. Buying the dip for a value contrarian involves identifying fundamentally sound companies whose temporary price decline offers an even more attractive entry point.</li>
</ul>
<ul>
<li>The Sentiment Contrarian: This investor bets against prevailing market sentiment, often buying when fear and pessimism are rampant. They believe that markets tend to overreact, creating opportunities to profit from the eventual correction. For this type, buying the dip is about capitalizing on widespread panic, assuming the underlying fundamentals are not severely compromised.</li>
</ul>
<ul>
<li>The Catalyst-Driven Contrarian: This investor looks for companies facing temporary setbacks or negative news that they believe will eventually be resolved. They buy in anticipation of a specific catalyst that will trigger a positive re-evaluation by the market. Buying the dip here is a calculated bet on a turnaround or the dissipation of current concerns.</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul>
<li>On Monday, March&#8217;s data on the U.S. leading economic indicators will be released by 10:00 a.m. ET.</li>
</ul>
<ul>
<li>On Tuesday, Philadelphia Fed President Patrick Harker will speak at 9:30 a.m., Minneapolis Fed President Neel Kashkari will speak at 2:00 p.m., and Richmond Fed President Tom Barkin will speak at 2:30 p.m. ET.</li>
</ul>
<ul>
<li>On Wednesday, Chicago Fed President Austan Goolsbee will speak at 9:00 a.m., whereas St. Louis Fed President Alberton Musalem and Fed Governor Christopher Waller speak after that at 9:30 a.m. ET.</li>
</ul>
<ul>
<li>April&#8217;s S&amp;P flash U.S. services and manufacturing PMI will be announced by 9:45 a.m., and new home sales data for March will be out by 10:00 a.m. ET.</li>
</ul>
<ul>
<li>Fed Beige Book will be out by 2:00 p.m., and Cleveland Fed President Beth Hammack will speak at 6:30 p.m. ET.</li>
</ul>
<ul>
<li>Atlanta Fed President Raphael Bostic will speak at 7:40 p.m. ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims for the week ended April 19, along with March&#8217;s durable-goods orders data, will be out by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>Existing home sales for March will be released by 10:00 a.m., and Minneapolis Fed President Kashkari will speak again at 5:00 p.m. ET.</li>
</ul>
<ul>
<li>On Friday, April&#8217;s final consumer sentiment data will be announced by 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) rose 0.19% in premarket on Monday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $1.13 per share on revenue of $831.34 million.</li>
</ul>
<ul>
<li>AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) declined 2.47% as Wall Street expects it to report earnings of 98 cents per share on revenue of $368.55 billion after the closing bell.</li>
</ul>
<ul>
<li>Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) jumped 2.90% after reporting stronger-than-expected first-quarter financial results after the closing bell on Thursday. The company said it expects second-quarter revenue of $11.04 billion and earnings per share of $6.61.</li>
</ul>
<ul>
<li>Minerals Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) dropped 3.28% after issuing preliminary results for the first quarter, expecting revenue of $492 million for the quarter.</li>
</ul>
<ul>
<li>HIVE Digital Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) advanced 4.03% after announcing the completion of the first 100 MW infrastructure in Paraguay.</li>
</ul>
<ul>
<li>SHF Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>) zoomed 71.30% after it partnered with FundCanna to provide compliant banking and accessible credit facilities to cannabis-related businesses nationwide.</li>
</ul>
<ul>
<li>Vincerx Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) slumped 47.27% as it announced its intention to delist from Nasdaq and deregister with the SEC after receiving a non-compliance notice from Nasdaq on April 14.</li>
</ul>
<ul>
<li>Thunder Power Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) plunged 26.78% after Western Capital Resources completed its tender offer on April 17, accepting 680,087 shares or 7.7% of the former&#8217;s outstanding shares, exceeding its initial target and accommodating all valid tenders.</li>
</ul>
<ul>
<li>Snow Lake Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) lost 26.32% as it announced an update on its share repurchase program without disclosing the exact number of shares repurchased, using its corporate funds for buyback.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 2.67% to hover around $62.30 per barrel.
Gold Spot US Dollar advanced 2.007% to hover around $3,394.03 per ounce. Its fresh record high stood at $3,396.57 per ounce. The U.S. Dollar Index spot was lower by 1.30% at the 97.9410 level.
Asian markets advanced on Wednesday, except Japan's Nikkei 225 index. India's S&amp;P BSE Sensex, Hong Kong's Hang Seng, China&#8217;s CSI 300, Australia's ASX 200, and South Korea's Kospi index ended higher. European markets were mostly lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44891949/chinese-commerce-ministry-pledges-retaliation-against-countries-isolating-beijing-with-us-at-the-expense-of-china">Xi Jinping&#8217;s China Pledges Retaliation Against Countries Isolating Beijing By Giving Into Trump Administration&#8217;s &#8216;Unilateral Bullying,&#8217; Says It Will &#8216;Never Accept It&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Economics

Federal Reserve

Analyst Ratings

HIVE

LITM

NVDA

VINC

US Stocks Likely To Open Lower: 'Best And Worst Days Tend To Occur Near The Same Time,' Says Expert

<h3>Companies Reporting Before The Bell</h3>
• MainStreet Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNSB#NASDAQ">MNSB</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $17.21 million. 
• HBT Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBT#NASDAQ">HBT</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $57.31 million. 
• Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.13 per share on revenue of $831.34 million. 
• Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) is expected to report earnings for its fourth quarter. 
• Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $11.41 million. 
• Washington Trust Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WASH#NASDAQ">WASH</a>) is estimated to report quarterly earnings at $0.63 per share on revenue of $53.16 million. 
• Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $169.27 million. 
• Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) is estimated to report quarterly earnings at $0.71 per share on revenue of $31.10 million. 
• Capital City Bank Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCBG#NASDAQ">CCBG</a>) is expected to report quarterly earnings at $0.74 per share on revenue of $59.75 million. 
• Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) is estimated to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is expected to report quarterly earnings at $1.78 per share on revenue of $791.97 million. 
• Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is likely to report quarterly earnings at $0.83 per share on revenue of $399.02 million. 
• SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) is likely to report quarterly earnings at $0.55 per share on revenue of $46.23 million. 
• Servisfirst Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NYSE">SFBS</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $134.10 million. 
• Home Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBCP#NASDAQ">HBCP</a>) is likely to report quarterly earnings at $1.14 per share on revenue of $30.90 million. 
• Trustco Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRST#NASDAQ">TRST</a>) is projected to report earnings for its first quarter. 
• AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) is estimated to report quarterly earnings at $0.98 per share on revenue of $367.78 million. 
• Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is estimated to report quarterly earnings at $1.56 per share on revenue of $68.40 million. 
• Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $478.67 million. 
• Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $795.15 million. 
• AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $436.71 million. 
• WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) is projected to report quarterly earnings at $1.04 per share on revenue of $3.02 billion. 
• Cathay General (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATY#NASDAQ">CATY</a>) is expected to report quarterly earnings at $0.95 per share on revenue of $186.16 million. 
• Wintrust Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) is likely to report quarterly earnings at $2.49 per share on revenue of $643.83 million. 
• Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $206.98 million. 
• Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) is expected to report quarterly earnings at $0.64 per share on revenue of $451.05 million. 
• Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) is likely to report quarterly earnings at $0.81 per share on revenue of $109.47 million. 
• BOK Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOKF#NASDAQ">BOKF</a>) is likely to report quarterly earnings at $1.99 per share on revenue of $520.72 million. 
• Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) is estimated to report quarterly earnings at $3.09 per share on revenue of $540.55 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADXN

AGNC

BOKF

CADE

CALX

CATY

CCBG

FLXS

GNTY

HBCP

MEDP

MNSB

SFBS

SMBK

TRST

WASH

WTFC

Earnings Scheduled For April 21, 2025

The CNN Money Fear and Greed index remained in the &#8220;Extreme Fear&#8221; zone on Friday.
U.S. stocks settled mostly lower on Thursday, with the Dow Jones index falling more than 500 points during the session. The 30-stock index recorded losses for the third day, while all three major indices closed the holiday-shortened trading week on a lower note.
UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares dipped over 22% on Thursday after the company reported worse-than-expected first-quarter results and cut its FY25 adjusted EPS guidance below estimates. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares fell around 3% on Thursday, after declining around 7% in the previous session.
However, Eli Lilly &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) shares staged their sharpest single-day rally in nearly 25 years Thursday, after unveiling data from a pivotal trial that could cement its leadership in a weight-loss drug market projected to more than triple in size by 2030.
On the economic data front, U.S. housing starts dipped 11.4% month-over-month to an annualized rate of 1.324 million in March. U.S. initial jobless claims declined by 9,000 from the previous week to 215,000 during the second week of April, versus market estimates of 225,000. The Philadelphia Fed Manufacturing Index fell 39 points to a reading of -26.4 in April, and down from market estimates of 2.
Most sectors on the S&amp;P 500 closed on a positive note, with energy, consumer staples, and real estate stocks recording the biggest gains on Thursday. However, information technology and health care stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 527 points to 39,142.23 on Thursday. The S&amp;P 500 rose 0.13% to 5,282.70, while the Nasdaq Composite fell 0.13% to 16,286.45 during Thursday's session.
Investors are awaiting earnings results from Zions Bancorporation, National Association (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>), and Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 20.9, the index remained in the &#8220;Extreme Fear&#8221; zone on Friday, versus a prior reading of 21.4.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo courtesy: Shutterstock

Dow Dips Over 500 Points, Down For 3rd Straight Session As UnitedHealth Tanks: Greed Index Remains In 'Extreme Fear' Zone

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) to report quarterly earnings at $1.13 per share on revenue of $831.34 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Comerica shares gained 0.2% to $53.05 in after-hours trading.</li>
<li>Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) reported stronger-than-expected first-quarter financial results after the closing bell on Thursday. The company said it expects second-quarter revenue of $11.04 billion and earnings per share of $6.61. Netflix shares gained 3.4% to $1,006.00 in the after-hours trading session.</li>
<li>Analysts are expecting AZZ Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) to post quarterly earnings at 98 cents per share on revenue of $368.55 billion. The company will release earnings after the markets close. AZZ shares rose 1.2% to $82.00 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Minerals Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) issued preliminary results for the first quarter, expecting revenue of $492 million for the quarter. Minerals Technologies shares fell 1.8% to $55.71 in the after-hours trading session.</li>
<li>Analysts expect Zions Bancorporation, National Association (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) to post quarterly earnings at $1.18 per share on revenue of $797.07 million after the closing bell. Zions Bancorporation shares gained 1.5% to $44.95 in after-hours trading.</li>
</ul>
Check This Out:<a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/04/44862261/top-3-materials-stocks-that-are-ticking-portfolio-bombs">Top 3 Materials Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Comerica, Netflix And 3 Stocks To Watch Heading Into Monday

Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is preparing to release its quarterly earnings on Monday, 2025-04-21. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Comerica to report an earnings per share (EPS) of $1.13.
Comerica bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.06, leading to a 0.26% drop in the share price on the subsequent day.
Here's a look at Comerica's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.26</td>
<td>1.16</td>
<td>1.19</td>
<td>1.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.20</td>
<td>1.37</td>
<td>1.53</td>
<td>1.29</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>4.0%</td>
<td>-10.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744984824_0.png" alt="eps graph" />
<h3>Performance of Comerica Shares</h3>
Shares of Comerica were trading at $52.54 as of April 16. Over the last 52-week period, shares are up 0.65%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CMA/earnings">To track all earnings releases for Comerica visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Comerica's Earnings Potential

Rumors

Watching Comerica; Hearing U.S. Consumer Financial Protection Bureau Dismisses Case Against Comerica Bank

UBS analyst Nicholas Holowko upgrades Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) from Sell to Neutral and announces $59 price target.

Upgrades

Price Target

UBS Upgrades Comerica to Neutral, Announces $59 Price Target

WIIM

ALLY

ARCC

ARES

EWBC

FITB

HBAN

HOMB

HSBC

IBKR

NDAQ

NTRS

RITM

SCHW

SOFI

SPGI

TROW

VOYA

Shares of banks and financial services companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

AFCG

BXMT

CFFI

CMTG

CODI

FUNC

GLAD

GPMT

OVBC

SBCF

STWD

TCBX

TRMK

Shares of broader financial companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Morgan Stanley analyst Manan Gosalia downgrades Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) from Equal-Weight to Underweight and lowers the price target from $63 to $55.

Downgrades

Morgan Stanley Downgrades Comerica to Underweight, Lowers Price Target to $55

Raymond James analyst Michael Rose maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Outperform and lowers the price target from $72 to $67.

Raymond James Maintains Outperform on Comerica, Lowers Price Target to $67

Stephens &amp; Co. analyst Terry McEvoy downgrades Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) from Overweight to Equal-Weight and lowers the price target from $66 to $64.

Stephens & Co. Downgrades Comerica to Equal-Weight, Lowers Price Target to $64

Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) underwent analysis by 12 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $71.42, a high estimate of $80.00, and a low estimate of $63.00. Experiencing a 4.67% decline, the current average is now lower than the previous average price target of $74.92. 
<img src="https://www.benzinga.com/files/images/story/2025/1743188517_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Comerica. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$67.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$71.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$76.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$67.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$77.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$68.00</td>
<td>$66.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Comerica. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Comerica compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Comerica's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CMA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Comerica analyst ratings.</a>
<h2>Discovering Comerica: A Closer Look</h2>
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
<h3>Understanding the Numbers: Comerica's Finances</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Comerica's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 5.5%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Comerica's net margin is impressive, surpassing industry averages. With a net margin of 19.76%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.48%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Comerica's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.21%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.09.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 12 Analysts Discuss Comerica Stock

Wells Fargo analyst Mike Mayo maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Equal-Weight and lowers the price target from $70 to $67.

Wells Fargo Maintains Equal-Weight on Comerica, Lowers Price Target to $67

Morgan Stanley analyst Manan Gosalia maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Equal-Weight and lowers the price target from $71 to $63.

Morgan Stanley Maintains Equal-Weight on Comerica, Lowers Price Target to $63

In the latest quarter, 12 analysts provided ratings for Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $72.58, a high estimate of $80.00, and a low estimate of $64.00. A 1.25% drop is evident in the current average compared to the previous average price target of $73.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1741197616_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Comerica is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Terry McEvoy</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$71.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$76.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$67.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$77.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$68.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Nicholas Holowko</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$64.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Comerica. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Comerica compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Comerica's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Comerica's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CMA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Comerica analyst ratings.</a>
<h2>About Comerica</h2>
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
<h3>Unraveling the Financial Story of Comerica</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Comerica displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 5.5%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Comerica's net margin is impressive, surpassing industry averages. With a net margin of 19.76%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.48%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Comerica's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.21%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Comerica's debt-to-equity ratio is below the industry average at 1.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Comerica: Insights From 12 Analyst Reviews

Stephens &amp; Co. analyst Terry McEvoy reiterates Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Overweight and maintains $72 price target.

Reiteration

Stephens & Co. Reiterates Overweight on Comerica, Maintains $72 Price Target

16 analysts have shared their evaluations of Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Comerica, revealing an average target of $74.44, a high estimate of $85.00, and a low estimate of $64.00. This current average has increased by 4.2% from the previous average price target of $71.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1739282573_0_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Comerica among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$71.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Karl Shepard</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$76.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$67.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$77.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$68.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Nicholas Holowko</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$64.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$72.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>David George</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$73.00</td>
<td>$51.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Comerica. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Comerica compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Comerica's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Comerica's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CMA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Comerica analyst ratings.</a>
<h2>Delving into Comerica's Background</h2>
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
<h3>Unraveling the Financial Story of Comerica</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Comerica's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 1.11%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Comerica's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.88%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Comerica's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.48%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Comerica's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Comerica's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.09.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Comerica: Insights From 16 Analyst Reviews

Press Releases

Comerica Bank Names Troy Norris Arizona Market President

Detroit Pistons Shine Spotlight on Seven Small Businesses During February's SHOP313 Pop-Up Shops Presented by Comerica

Dividends

Comerica Declares Common and Preferred Stock Dividends

Comerica Recognized for Strength in Serving Businesses with Coalition Greenwich Awards

$100,000 Comerica Hatch Detroit Contest by TechTown Returns with Increased Support from Comerica Bank

Comerica Bank's Shred Day Houston Returns on April 5

Comerica Bank to hold Seventh Annual Prom Dress Drive, Benefiting Jackets for Jobs

Comerica Bank Executive Vice President Joe Ursuy Elected to National Waste & Recycling Association Hall of Fame

Protect Your Identity, the Planet at 13th Annual Comerica Bank Shred Day DFW on April 12

Comerica Reports First Quarter 2025 Earnings Results

Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones

Credicorp

Banco BBVA Argentina

Banco Bradesco Sa American Depositary Shares (each representing one Common Share)

Bank Bradesco

Banco De Chile

Banco Macro S.A. ADR (representing Ten Class B Common Shares)

Banco Macro

Banco Santander Chile

BanColombia

First Citizens BancShares, Inc. - Class A Common Stock

First Citizens BancShares

Fifth Third Bancorp

Grupo Financiero Galicia S.A. - American Depositary Shares, Class B Shares underlying

Grupo Financiero Galicia

Intercorp Financial Services Inc. Common Shares

Intercorp Financial Servs

Inter & Co

KB Financial Group

KeyCorp

Shinhan Financial Group Co Ltd American Depositary Shares

Shinhan Finl Gr

Grupo Supervielle S.A. American Depositary Shares each Representing five Class B shares

Grupo Supervielle

Woori Financial Group Inc. American Depositary Shares (each representing three (3) shares of Common Stock)

Comments

Comerica

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL